Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

U.S. CDC Says Administered 460.8 Million Doses Of Covid-19 Vaccine As Of Nov 30

11/30/2021 | 04:52pm EST

Nov 30 (Reuters) - U.S. CDC:

* U.S. CDC SAYS AS OF NOVEMBER 30, 41,126,064 PEOPLE RECEIVED A BOOSTER DOSE FOR COVID-19 VACCINE SINCE AUGUST 13, 2021

* U.S. CDC SAYS 197,058,988 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF NOV 30 VERSUS 196,806,194 INDIVIDUALS AS OF NOV 29

* U.S. CDC SAYS ADMINISTERED 460,773,508 DOSES OF COVID-19 VACCINE AS OF NOV 30 VERSUS 459,234,791 DOSES AS OF NOV 29

* U.S. CDC SAYS 233,207,582 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF NOV 30 VERSUS 232,792,508 INDIVIDUALS AS OF NOV 29

* U.S. CDC SAYS DELIVERED 573,238,255 DOSES OF COVID-19 VACCINE AS OF NOV 30 VERSUS 570,662,725 DOSES AS OF NOV 29


ę Reuters 2021
All news about MODERNA, INC.
01/18US Stocks Slump as Treasury Yields Hit 2-Year High, Goldman Sachs Weighs on Financials
MT
01/18US Stocks Start Week Lower as Treasury Yields Hit 2-Year High, Goldman Sachs Weighs on ..
MT
01/18Morgan Stanley Adjusts Moderna Price Target to $315 From $313, Maintains Equal Weight R..
MT
01/18Equities Slump Midday After Treasury Yields Touch Two-Year High, Goldman's Earnings Mis..
MT
01/18MIDDAY REPORT : US Stocks Slump After Treasury Yields Touch Two-Year High; Goldman's Earni..
MT
01/18EU regulator finds mRNA COVID-19 shots safe during pregnancy
RE
01/18European Medicines Agency Says mRNA COVID-19 Vaccines Safe In Pregnancy
MT
01/18EU regulator says mRNA COVID-19 shots do not complicate pregnancies
RE
01/18MARKETSCREENER’S WORLD PRESS REVIEW : January 18, 2022
01/17China's Xi rejects 'Cold War mentality,' pushes cooperation
AQ
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 17 520 M - -
Net income 2021 11 079 M - -
Net cash 2021 9 774 M - -
P/E ratio 2021 7,07x
Yield 2021 -
Capitalization 75 661 M 75 661 M -
EV / Sales 2021 3,76x
EV / Sales 2022 2,60x
Nbr of Employees 1 300
Free-Float 90,5%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Last Close Price 186,61 $
Average target price 273,19 $
Spread / Average Target 46,4%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-26.53%75 661
LONZA GROUP AG-15.05%52 427
IQVIA HOLDINGS INC.-14.11%46 293
SEAGEN INC.-15.72%23 824
ICON PUBLIC LIMITED COMPANY-17.86%20 707
CELLTRION, INC.-19.44%18 630